Thomas Milz
Corporate Officer/Principal chez APONTIS PHARMA AG
Profil
Thomas Milz is currently the Co-Managing Director at PP Apontis Pharma GmbH and the Chief Product Officer at APONTIS PHARMA AG.
Previously, he held positions such as Director-Strategic Projects & Market Access at UCB Pharma GmbH from 2007 to 2016, Director-Strategic Business Development at APONTIS PHARMA.
Deutschland GmbH & Co. KG from 2017 to 2018 and from 2019 to 2021, Marketing Manager at Schwarz Pharma Deutschland GmbH from 1999 to 2007, Marketing Manager at Sanol GmbH from 1999 to 2007, and Manager-Product Regulations at Madaus AG from 1996 to 1997.
He also worked as a Manager-Prostavasin Product at UCB Pharma GmbH from 1993 to 1996.
Mr. Milz obtained his undergraduate degree from Fachhochschule Düsseldorf in 1991.
Postes actifs de Thomas Milz
| Sociétés | Poste | Début |
|---|---|---|
| APONTIS PHARMA AG | Corporate Officer/Principal | 01/01/2021 |
PP Apontis Pharma GmbH
 PP Apontis Pharma GmbH Financial ConglomeratesFinance PP Apontis Pharma GmbH is an investment holding German company. The company is based in Monheim am Rhein, Germany. The CEOs are Thomas Milz and Thomas Zimmermann. The private company was founded in 2019. | Chief Executive Officer | 01/05/2021 |
Anciens postes connus de Thomas Milz
| Sociétés | Poste | Fin |
|---|---|---|
Apontis Pharma GmbH & Co. KG
 Apontis Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology APONTIS PHARMA Deutschland GmbH & Co. KG engages in the wholesale of pharmaceutical products. It focuses on medicines used for the treatment of chronic obstructive pulmonary diseases, hypertension, and cardiovascular diseases. The company was founded on February 13, 2015 and is headquartered in Monheim, Germany. | Corporate Officer/Principal | 01/01/2018 |
UCB Pharma GmbH
 UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Corporate Officer/Principal | 01/01/2016 |
| Schwarz Pharma Deutschland GmbH | Corporate Officer/Principal | 01/01/1999 |
| Sanol GmbH | Sales & Marketing | 01/01/2007 |
| Madaus AG | Corporate Officer/Principal | 01/01/1997 |
Formation de Thomas Milz
| Fachhochschule Düsseldorf | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| APONTIS PHARMA AG | Health Technology |
| Entreprise privées | 6 |
|---|---|
UCB Pharma GmbH
UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Health Technology |
| Schwarz Pharma Deutschland GmbH | |
Apontis Pharma GmbH & Co. KG
Apontis Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology APONTIS PHARMA Deutschland GmbH & Co. KG engages in the wholesale of pharmaceutical products. It focuses on medicines used for the treatment of chronic obstructive pulmonary diseases, hypertension, and cardiovascular diseases. The company was founded on February 13, 2015 and is headquartered in Monheim, Germany. | Health Technology |
PP Apontis Pharma GmbH
PP Apontis Pharma GmbH Financial ConglomeratesFinance PP Apontis Pharma GmbH is an investment holding German company. The company is based in Monheim am Rhein, Germany. The CEOs are Thomas Milz and Thomas Zimmermann. The private company was founded in 2019. | Finance |
| Sanol GmbH | |
| Madaus AG |
